These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37766787)

  • 41. Oxidative Stress-Induced Axon Fragmentation Is a Consequence of Reduced Axonal Transport in Hereditary Spastic Paraplegia
    Wali G; Liyanage E; Blair NF; Sutharsan R; Park JS; Mackay-Sim A; Sue CM
    Front Neurosci; 2020; 14():401. PubMed ID: 32457567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese.
    Dong Y; Li XY; Wang XL; Xu F; Wang ZJ; Song Y; Li Q; Lin R; Wang C
    Neurosci Lett; 2021 Sep; 761():136108. PubMed ID: 34256108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of novel compound heterozygous SPG7 mutations-related hereditary spastic paraplegia in a Chinese family: a case report.
    Zhang X; Zhang L; Wu Y; Li G; Chen S; Xia Y; Li H
    BMC Neurol; 2018 Nov; 18(1):196. PubMed ID: 30497413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptor protein complex 4 deficiency: a paradigm of childhood-onset hereditary spastic paraplegia caused by defective protein trafficking.
    Behne R; Teinert J; Wimmer M; D'Amore A; Davies AK; Scarrott JM; Eberhardt K; Brechmann B; Chen IP; Buttermore ED; Barrett L; Dwyer S; Chen T; Hirst J; Wiesener A; Segal D; Martinuzzi A; Duarte ST; Bennett JT; Bourinaris T; Houlden H; Roubertie A; Santorelli FM; Robinson M; Azzouz M; Lipton JO; Borner GHH; Sahin M; Ebrahimi-Fakhari D
    Hum Mol Genet; 2020 Jan; 29(2):320-334. PubMed ID: 31915823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation.
    Thal DR; Züchner S; Gierer S; Schulte C; Schöls L; Schüle R; Synofzik M
    Int J Mol Sci; 2015 Oct; 16(10):25050-66. PubMed ID: 26506339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genomic structure and expression analysis of the spastic paraplegia gene, SPG7.
    Settasatian C; Whitmore SA; Crawford J; Bilton RL; Cleton-Jansen AM; Sutherland GR; Callen DF
    Hum Genet; 1999; 105(1-2):139-44. PubMed ID: 10480368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model.
    Mishra HK; Prots I; Havlicek S; Kohl Z; Perez-Branguli F; Boerstler T; Anneser L; Minakaki G; Wend H; Hampl M; Leone M; Brückner M; Klucken J; Reis A; Boyer L; Schuierer G; Behrens J; Lampert A; Engel FB; Gage FH; Winkler J; Winner B
    Ann Neurol; 2016 May; 79(5):826-840. PubMed ID: 26971897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel compound heterozygous SPG7 variant is associated with progressive spastic ataxia and persecutory delusions found in Chinese patients: two case reports.
    Wang S; Wang Y; Wu Y; Zhang J; Zhang W; Li C; Song X
    BMC Neurol; 2022 May; 22(1):200. PubMed ID: 35637455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
    Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
    Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia.
    López E; Casasnovas C; Giménez J; Matilla-Dueñas A; Sánchez I; Volpini V
    Neurogenetics; 2015 Apr; 16(2):97-105. PubMed ID: 25398481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and phenotypic characterization of complex hereditary spastic paraplegia.
    Kara E; Tucci A; Manzoni C; Lynch DS; Elpidorou M; Bettencourt C; Chelban V; Manole A; Hamed SA; Haridy NA; Federoff M; Preza E; Hughes D; Pittman A; Jaunmuktane Z; Brandner S; Xiromerisiou G; Wiethoff S; Schottlaender L; Proukakis C; Morris H; Warner T; Bhatia KP; Korlipara LV; Singleton AB; Hardy J; Wood NW; Lewis PA; Houlden H
    Brain; 2016 Jul; 139(Pt 7):1904-18. PubMed ID: 27217339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPG7 targets the m-AAA protease complex to process MCU for uniporter assembly, Ca
    Hurst S; Baggett A; Csordas G; Sheu SS
    J Biol Chem; 2019 Jul; 294(28):10807-10818. PubMed ID: 31097542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cold temperature improves mobility and survival in Drosophila models of autosomal-dominant hereditary spastic paraplegia (AD-HSP).
    Baxter SL; Allard DE; Crowl C; Sherwood NT
    Dis Model Mech; 2014 Aug; 7(8):1005-12. PubMed ID: 24906373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia.
    Arnoldi A; Tonelli A; Crippa F; Villani G; Pacelli C; Sironi M; Pozzoli U; D'Angelo MG; Meola G; Martinuzzi A; Crimella C; Redaelli F; Panzeri C; Renieri A; Comi GP; Turconi AC; Bresolin N; Bassi MT
    Hum Mutat; 2008 Apr; 29(4):522-31. PubMed ID: 18200586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optochemogenetic Stimulation of Transplanted iPS-NPCs Enhances Neuronal Repair and Functional Recovery after Ischemic Stroke.
    Yu SP; Tung JK; Wei ZZ; Chen D; Berglund K; Zhong W; Zhang JY; Gu X; Song M; Gross RE; Lin SZ; Wei L
    J Neurosci; 2019 Aug; 39(33):6571-6594. PubMed ID: 31263065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
    Baviera-Muñoz R; Campins-Romeu M; Carretero-Vilarroig L; Sastre-Bataller I; Martínez-Torres I; Vázquez-Costa JF; Muelas N; Sevilla T; Vílchez JJ; Aller E; Jaijo T; Bataller L; Espinós C
    J Neurol Sci; 2021 Oct; 429():118062. PubMed ID: 34500365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model.
    Deng R; Medico-Salsench E; Nikoncuk A; Ramakrishnan R; Lanko K; Kühn NA; van der Linde HC; Lor-Zade S; Albuainain F; Shi Y; Yousefi S; Capo I; van den Herik EM; van Slegtenhorst M; van Minkelen R; Geeven G; Mulder MT; Ruijter GJG; Lütjohann D; Jacobs EH; Houlden H; Pagnamenta AT; Metcalfe K; Jackson A; Banka S; De Simone L; Schwaede A; Kuntz N; Palculict TB; Abbas S; Umair M; AlMuhaizea M; Colak D; AlQudairy H; Alsagob M; Pereira C; Trunzo R; Karageorgou V; Bertoli-Avella AM; Bauer P; Bouman A; Hoefsloot LH; van Ham TJ; Issa M; Zaki MS; Gleeson JG; Willemsen R; Kaya N; Arold ST; Maroofian R; Sanderson LE; Barakat TS
    Acta Neuropathol; 2023 Aug; 146(2):353-368. PubMed ID: 37119330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands.
    Balicza P; Grosz Z; Gonzalez MA; Bencsik R; Pentelenyi K; Gal A; Varga E; Klivenyi P; Koller J; Züchner S; Molnar JM
    J Neurol Sci; 2016 May; 364():116-21. PubMed ID: 27084228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis.
    Fereshtehnejad SM; Saleh PA; Oliveira LM; Patel N; Bhowmick S; Saranza G; Kalia LV
    Neurol Sci; 2023 Mar; 44(3):947-959. PubMed ID: 36441344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expanding SPG7 dominant optic atrophy phenotype: Infantile nystagmus and optic atrophy without spastic paraplegia.
    Seo Y; Lim HT; Lee BJ; Han J
    Am J Med Genet A; 2023 Feb; 191(2):582-585. PubMed ID: 36367250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.